닫기
Infraware Technology
FAMILY SITE
Slide background

Solutions from Process Development to Commercial Manufacturing for Monoclonal Antibodies

Scalable and Cost-Efficient Single-Use Toolbox for Your mAb Process Platform

By combining our expertise in cell line development and cultivation, media optimization, virus clearance, filtration and polishing of mAbs we provide a complete Toolbox of Solutions which can be adapted in-house or at contract manufacturing organizations.

mAbs | Upstream

Speed your Upstream Development and Simplify Manufacturing – From 15 mL to 2000 L

mAbs | Downstream

Tackle your Downstream Bottlenecks – From mg to kg of mAbs

Intensified Processing

Technologies that enable intensified production throughout the process

An Interview with Synthon

In an exclusive interview with Miriam Monge, Head of Segment Marketing mAb at Sartorius, Nienke Vriezen, Synthon’s Director of USP Development and Manufacturing talks about how Sartorius helped Synthon to rapidly implement a flexible single-use facility for the manufacture of monoclonal antibodies.
Founded in 1991, Synthon now employs 1,700 people at nine sites worldwide. The company develops biopharmaceuticals with a focus is on next-generation cancer drugs.

Explore the Sartorius Bioreactor and Process Control Range

Vaccine Manufacturing, Process Development and Production

Regenerative Medicine

Bioconjugation

Copyright © 2020. Satorius. All rights reserved.
싸토리우스코리아 웹사이트는 귀하의 사용자 경험을 개선하고 귀하의 관심사에 맞는 콘텐츠를 제공하기 위해 쿠키를 사용합니다.
본인은 Sartorius가 사용자 프로필을 생성하고 관심있는 관련 있는 광고를 제공하기 위해 본인과 관련된 데이터를 처리하는 데 동의합니다.
이 동의는 자발적이며 이 웹사이트를 사용하는데 필요하지 않으며 향후 언제든지 철회할 수 있습니다.
동의
거부